Ecole Polytechnique Fédérale de Lausanne Jan 16 2026 In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug can safely lower triglycerides and other blood lipids. When we eat, our bodies convert extra calories, especially from carbs, sugar, fats, and alcohol, into molecules called "triglycerides". Triglycerides are a form of fat or "lipid", which the body stores away into its fat cells as an energy fuel for energy between